Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yantai Ruikangda Biochemical Products is a specialized pharmaceutical manufacturer based in Yantai, China, focusing on the production of biochemical active pharmaceutical ingredients (APIs). The company is a prominent supplier of heparin-based products, including Heparin Sodium and Enoxaparin Sodium, which are essential for anticoagulant therapies. Utilizing advanced extraction and purification processes from porcine intestinal mucosa, the company serves both domestic and international markets. Their operations are characterized by a commitment to GMP standards, ensuring high-quality raw materials for the treatment of cardiovascular and thrombotic diseases. In addition to heparin products, the company manufactures other biochemicals such as Chondroitin Sulfate for use in the nutraceutical and pharmaceutical industries. The company plays a significant role in the global supply chain for life-saving anticoagulant medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yantai Ruikangda Biochemical Products.